BIOMEDICA NT-proBNP and NT-proANP ELISA kits for preclinical toxicology testing
Cardiac toxicity is a leading cause of preclinical safety failures in drug development. The cardiac markers NT-proANP and NT-proBNP have proven to be useful in preclinical toxicology testing.
The BIOMEDICA NT-proBNP and NT-proANP ELISA kits are robust assays to quantify these cardiac hormones in rat samples. The NT-proANP ELISA kit is widely published for use in rat samples and has been independently validated for cardiovascular safety studies in rats.
Features of these quantitative ELISAs for translational research and drug discovery include: only 10 µL/well required, serum or plasma; kit control included; sample values provided; widely cited; suitable for use in human and non-human samples (high cross-reactivity between species).
For further information, visit https://www.bmgrp.com/cardiac-safety-biomarker-assays-in-preclinical-toxicology/ or contact United Bioresearch Products, who distributes the full BIOMEDICA range in Australia, at (02) 4575 0309 or info@unitedbioresearch.com.au.
Phone: 02 4575 0309
Cayman Chemical Cellular Metabolism Screening Library
Cayman Chemical's Cellular Metabolism Screening Library consists of two plates and contains...
Navinci Diagnostics NaveniFlex Cell Red proximity ligation assay kit
Optimised for cell samples, the kit enables fluorescence visualisation of protein–protein...
Lonza TheraPEAK AmpliCell Cytokines and TheraPEAK 293-GT Medium
The products provide researchers and manufacturers with high-performance, scalable and...
Learn More
I am interested in BIOMEDICA NT-proBNP and NT-proANP ELISA kits for preclinical toxicology testing.
Complete the form and a supplier representative will be in touch.
